Select a month January 2004 December 2003 November 2003" October 2003 September 2003 July 2003 June 2003 May 2003 April 2003 March 2003 February 2003 January 2003 December 2002 November 2002 October 2002 September 2002 August 2002 July 2002 June 2002 May 2002 April 2002 March 2002 February 2002 January 2002 December 2001 November 2001 October 2001

Studies in Humans: Clinical Trials (Definition) Jump to: 2003: January  |  February  |  March  |  April  |   May  |   June  |   July  |   2002: January  |  February  |  March  |  April  |  May  |  June  |  July  |  August  |  September  |  October  |  November  |  December   2001: October  |  November  |  December November 2003 Tancer M and Johanson C-E (2003) Reinforcing, subjective and physiological effects of MDMA in humans; A comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence 72: 33-44. July 2003 No updates available for July 2003. June 2003 No updates available for June 2003 May 2003 No updates available for May 2003 April 2003 No updates available for April 2003. March 2003 Pizarro N, Llebaria A, Cano S, Joglar J, Farre M, Segura J, Torre Rd Rde L (2003) Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 17: 330-336 February 2003 No updates available for February 2003 January 2003 No updates available for January 2003 December 2002 No updates available for December 2002 November 2002 No updates available for November 2002 October 2002 No updates available for October 2002 September 2002 Samyn N, De Boeck G, Wood M, Lamers C, De Waard D, Brookhuis K, Verstraete A, Riedel W (2002) Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci Int 128: 90-97 (Study 1) Samyn N, De Boeck G, Wood M, Lamers C, De Waard D, Brookhuis K, Verstraete A, Riedel W (2002) Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci Int 128: 90-97 (Study 2) August 2002 Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Palmi I, Ortuno J, Menoyo E, Segura J, de la Torre R (2002) Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Ann N Y Acad Sci 965: 421-433 (Study 1) Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Palmi I, Ortuno J, Menoyo E, Segura J, de la Torre R (2002) Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Ann N Y Acad Sci 965: 421-433 (Study 2) July 2002 Harris DS, Baggott M, Mendelson J, Mendelson JE, Jones RT (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 162: 396-405. June 2002 No updates available for June 2002 May 2002 Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, Cami J, de la Torre R (2002). Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26: 157-165. April 2002 No updates available for April 2002 March 2002 Pichini S, Navarro M, Farre M, Ortuno J, Roset PN, Pacifici R, Zuccaro P, Segura J, de la Torre R (2002). On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in saliva with Drugwipe and Drugread: a controlled study in recreational users. Clin Chem 48: 174-6. February 2002 No updates available for February 2002 January 2002 Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R (2002). 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300: 236-44. December 2001 Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R (2001). Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans. Life Sci 69: 2931-41. (Study 1) Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R (2001). Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans. Life Sci 69: 2931-41. (Study 2) November 2001 Forsling, M, Fallon, JA, Kicman, AT, Hutt, AJ, Cowan, DA and Henry, JA (2001). Arginine vasopressin release in response to the administration of 3,4- methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor? Journal of Pharmacy and Pharmacology, 53: 1357-1363. Tancer, ME and Johanson, C-E (2001). The subjective effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence, 65: 97-101. October 2001 Frei, E, Gamma, A, Pascual-Marqui, R, Lehmann, D, Hell, D and Vollenweider, FX (2001). Localization of MDMA-induced brain activity in healthy volunteers using low-resolution brain electromagnetic tomography (LORETA). Human Brain Mapping, 14: 152-165. Navarro, M, Pichini, S, Farre, M, Ortuno, J, Roset, PN, Segura, J, de la Torre, R (2001). Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: Correlation with plasma drug concentrations and effect of salivary pH. Clinical Chemistry, 47: 1788-1795. Segura, M, Ortuno, J, Farre, M, McLure, JA, Pujadas, M, Pizarro, N, Llebaria, A, Juglar, J, Roset, PN, Segura, J, and de la Torre, R (2001). 3,4-dihydroxymethamphetamine (HHMA): a major in-vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chemical Research in Toxicology, 14: 1203-1208.